Adaptation of Oxford Nanopore technology for hepatitis C whole genome sequencing and identification of within-host viral variants
Background Hepatitis C (HCV) and many other RNA viruses exist as rapidly mutating quasi-species populations in a single infected host. High throughput characterization of full genome, within-host variants is still not possible despite advances in next generation sequencing. This limitation constrain...
Saved in:
| Published in | BMC genomics Vol. 22; no. 1; pp. 148 - 12 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
02.03.2021
BioMed Central Ltd Springer Nature B.V BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1471-2164 1471-2164 |
| DOI | 10.1186/s12864-021-07460-1 |
Cover
| Abstract | Background
Hepatitis C (HCV) and many other RNA viruses exist as rapidly mutating quasi-species populations in a single infected host. High throughput characterization of full genome, within-host variants is still not possible despite advances in next generation sequencing. This limitation constrains viral genomic studies that depend on accurate identification of hemi-genome or whole genome, within-host variants, especially those occurring at low frequencies. With the advent of third generation long read sequencing technologies, including Oxford Nanopore Technology (ONT) and PacBio platforms, this problem is potentially surmountable. ONT is particularly attractive in this regard due to the portable nature of the MinION sequencer, which makes real-time sequencing in remote and resource-limited locations possible. However, this technology (termed here ‘nanopore sequencing’) has a comparatively high technical error rate. The present study aimed to assess the utility, accuracy and cost-effectiveness of nanopore sequencing for HCV genomes. We also introduce a new bioinformatics tool (Nano-Q) to differentiate within-host variants from nanopore sequencing.
Results
The Nanopore platform, when the coverage exceeded 300 reads, generated comparable consensus sequences to Illumina sequencing. Using HCV Envelope plasmids (~ 1800 nt) mixed in known proportions, the capacity of nanopore sequencing to reliably identify variants with an abundance as low as 0.1% was demonstrated, provided the autologous reference sequence was available to identify the matching reads. Successful pooling and nanopore sequencing of 52 samples from patients with HCV infection demonstrated its cost effectiveness (AUD$ 43 per sample with nanopore sequencing versus $100 with paired-end short read technology). The Nano-Q tool successfully separated between-host sequences, including those from the same subtype, by bulk sorting and phylogenetic clustering without an autologous reference sequence (using only a subtype-specific generic reference). The pipeline also identified within-host viral variants and their abundance when the parameters were appropriately adjusted.
Conclusion
Cost effective HCV whole genome sequencing and within-host variant identification without haplotype reconstruction are potential advantages of nanopore sequencing. |
|---|---|
| AbstractList | Abstract Background Hepatitis C (HCV) and many other RNA viruses exist as rapidly mutating quasi-species populations in a single infected host. High throughput characterization of full genome, within-host variants is still not possible despite advances in next generation sequencing. This limitation constrains viral genomic studies that depend on accurate identification of hemi-genome or whole genome, within-host variants, especially those occurring at low frequencies. With the advent of third generation long read sequencing technologies, including Oxford Nanopore Technology (ONT) and PacBio platforms, this problem is potentially surmountable. ONT is particularly attractive in this regard due to the portable nature of the MinION sequencer, which makes real-time sequencing in remote and resource-limited locations possible. However, this technology (termed here ‘nanopore sequencing’) has a comparatively high technical error rate. The present study aimed to assess the utility, accuracy and cost-effectiveness of nanopore sequencing for HCV genomes. We also introduce a new bioinformatics tool (Nano-Q) to differentiate within-host variants from nanopore sequencing. Results The Nanopore platform, when the coverage exceeded 300 reads, generated comparable consensus sequences to Illumina sequencing. Using HCV Envelope plasmids (~ 1800 nt) mixed in known proportions, the capacity of nanopore sequencing to reliably identify variants with an abundance as low as 0.1% was demonstrated, provided the autologous reference sequence was available to identify the matching reads. Successful pooling and nanopore sequencing of 52 samples from patients with HCV infection demonstrated its cost effectiveness (AUD$ 43 per sample with nanopore sequencing versus $100 with paired-end short read technology). The Nano-Q tool successfully separated between-host sequences, including those from the same subtype, by bulk sorting and phylogenetic clustering without an autologous reference sequence (using only a subtype-specific generic reference). The pipeline also identified within-host viral variants and their abundance when the parameters were appropriately adjusted. Conclusion Cost effective HCV whole genome sequencing and within-host variant identification without haplotype reconstruction are potential advantages of nanopore sequencing. Hepatitis C (HCV) and many other RNA viruses exist as rapidly mutating quasi-species populations in a single infected host. High throughput characterization of full genome, within-host variants is still not possible despite advances in next generation sequencing. This limitation constrains viral genomic studies that depend on accurate identification of hemi-genome or whole genome, within-host variants, especially those occurring at low frequencies. With the advent of third generation long read sequencing technologies, including Oxford Nanopore Technology (ONT) and PacBio platforms, this problem is potentially surmountable. ONT is particularly attractive in this regard due to the portable nature of the MinION sequencer, which makes real-time sequencing in remote and resource-limited locations possible. However, this technology (termed here 'nanopore sequencing') has a comparatively high technical error rate. The present study aimed to assess the utility, accuracy and cost-effectiveness of nanopore sequencing for HCV genomes. We also introduce a new bioinformatics tool (Nano-Q) to differentiate within-host variants from nanopore sequencing. The Nanopore platform, when the coverage exceeded 300 reads, generated comparable consensus sequences to Illumina sequencing. Using HCV Envelope plasmids (~ 1800 nt) mixed in known proportions, the capacity of nanopore sequencing to reliably identify variants with an abundance as low as 0.1% was demonstrated, provided the autologous reference sequence was available to identify the matching reads. Successful pooling and nanopore sequencing of 52 samples from patients with HCV infection demonstrated its cost effectiveness (AUD$ 43 per sample with nanopore sequencing versus $100 with paired-end short read technology). The Nano-Q tool successfully separated between-host sequences, including those from the same subtype, by bulk sorting and phylogenetic clustering without an autologous reference sequence (using only a subtype-specific generic reference). The pipeline also identified within-host viral variants and their abundance when the parameters were appropriately adjusted. Cost effective HCV whole genome sequencing and within-host variant identification without haplotype reconstruction are potential advantages of nanopore sequencing. Hepatitis C (HCV) and many other RNA viruses exist as rapidly mutating quasi-species populations in a single infected host. High throughput characterization of full genome, within-host variants is still not possible despite advances in next generation sequencing. This limitation constrains viral genomic studies that depend on accurate identification of hemi-genome or whole genome, within-host variants, especially those occurring at low frequencies. With the advent of third generation long read sequencing technologies, including Oxford Nanopore Technology (ONT) and PacBio platforms, this problem is potentially surmountable. ONT is particularly attractive in this regard due to the portable nature of the MinION sequencer, which makes real-time sequencing in remote and resource-limited locations possible. However, this technology (termed here 'nanopore sequencing') has a comparatively high technical error rate. The present study aimed to assess the utility, accuracy and cost-effectiveness of nanopore sequencing for HCV genomes. We also introduce a new bioinformatics tool (Nano-Q) to differentiate within-host variants from nanopore sequencing.BACKGROUNDHepatitis C (HCV) and many other RNA viruses exist as rapidly mutating quasi-species populations in a single infected host. High throughput characterization of full genome, within-host variants is still not possible despite advances in next generation sequencing. This limitation constrains viral genomic studies that depend on accurate identification of hemi-genome or whole genome, within-host variants, especially those occurring at low frequencies. With the advent of third generation long read sequencing technologies, including Oxford Nanopore Technology (ONT) and PacBio platforms, this problem is potentially surmountable. ONT is particularly attractive in this regard due to the portable nature of the MinION sequencer, which makes real-time sequencing in remote and resource-limited locations possible. However, this technology (termed here 'nanopore sequencing') has a comparatively high technical error rate. The present study aimed to assess the utility, accuracy and cost-effectiveness of nanopore sequencing for HCV genomes. We also introduce a new bioinformatics tool (Nano-Q) to differentiate within-host variants from nanopore sequencing.The Nanopore platform, when the coverage exceeded 300 reads, generated comparable consensus sequences to Illumina sequencing. Using HCV Envelope plasmids (~ 1800 nt) mixed in known proportions, the capacity of nanopore sequencing to reliably identify variants with an abundance as low as 0.1% was demonstrated, provided the autologous reference sequence was available to identify the matching reads. Successful pooling and nanopore sequencing of 52 samples from patients with HCV infection demonstrated its cost effectiveness (AUD$ 43 per sample with nanopore sequencing versus $100 with paired-end short read technology). The Nano-Q tool successfully separated between-host sequences, including those from the same subtype, by bulk sorting and phylogenetic clustering without an autologous reference sequence (using only a subtype-specific generic reference). The pipeline also identified within-host viral variants and their abundance when the parameters were appropriately adjusted.RESULTSThe Nanopore platform, when the coverage exceeded 300 reads, generated comparable consensus sequences to Illumina sequencing. Using HCV Envelope plasmids (~ 1800 nt) mixed in known proportions, the capacity of nanopore sequencing to reliably identify variants with an abundance as low as 0.1% was demonstrated, provided the autologous reference sequence was available to identify the matching reads. Successful pooling and nanopore sequencing of 52 samples from patients with HCV infection demonstrated its cost effectiveness (AUD$ 43 per sample with nanopore sequencing versus $100 with paired-end short read technology). The Nano-Q tool successfully separated between-host sequences, including those from the same subtype, by bulk sorting and phylogenetic clustering without an autologous reference sequence (using only a subtype-specific generic reference). The pipeline also identified within-host viral variants and their abundance when the parameters were appropriately adjusted.Cost effective HCV whole genome sequencing and within-host variant identification without haplotype reconstruction are potential advantages of nanopore sequencing.CONCLUSIONCost effective HCV whole genome sequencing and within-host variant identification without haplotype reconstruction are potential advantages of nanopore sequencing. Background Hepatitis C (HCV) and many other RNA viruses exist as rapidly mutating quasi-species populations in a single infected host. High throughput characterization of full genome, within-host variants is still not possible despite advances in next generation sequencing. This limitation constrains viral genomic studies that depend on accurate identification of hemi-genome or whole genome, within-host variants, especially those occurring at low frequencies. With the advent of third generation long read sequencing technologies, including Oxford Nanopore Technology (ONT) and PacBio platforms, this problem is potentially surmountable. ONT is particularly attractive in this regard due to the portable nature of the MinION sequencer, which makes real-time sequencing in remote and resource-limited locations possible. However, this technology (termed here ‘nanopore sequencing’) has a comparatively high technical error rate. The present study aimed to assess the utility, accuracy and cost-effectiveness of nanopore sequencing for HCV genomes. We also introduce a new bioinformatics tool (Nano-Q) to differentiate within-host variants from nanopore sequencing. Results The Nanopore platform, when the coverage exceeded 300 reads, generated comparable consensus sequences to Illumina sequencing. Using HCV Envelope plasmids (~ 1800 nt) mixed in known proportions, the capacity of nanopore sequencing to reliably identify variants with an abundance as low as 0.1% was demonstrated, provided the autologous reference sequence was available to identify the matching reads. Successful pooling and nanopore sequencing of 52 samples from patients with HCV infection demonstrated its cost effectiveness (AUD$ 43 per sample with nanopore sequencing versus $100 with paired-end short read technology). The Nano-Q tool successfully separated between-host sequences, including those from the same subtype, by bulk sorting and phylogenetic clustering without an autologous reference sequence (using only a subtype-specific generic reference). The pipeline also identified within-host viral variants and their abundance when the parameters were appropriately adjusted. Conclusion Cost effective HCV whole genome sequencing and within-host variant identification without haplotype reconstruction are potential advantages of nanopore sequencing. Background Hepatitis C (HCV) and many other RNA viruses exist as rapidly mutating quasi-species populations in a single infected host. High throughput characterization of full genome, within-host variants is still not possible despite advances in next generation sequencing. This limitation constrains viral genomic studies that depend on accurate identification of hemi-genome or whole genome, within-host variants, especially those occurring at low frequencies. With the advent of third generation long read sequencing technologies, including Oxford Nanopore Technology (ONT) and PacBio platforms, this problem is potentially surmountable. ONT is particularly attractive in this regard due to the portable nature of the MinION sequencer, which makes real-time sequencing in remote and resource-limited locations possible. However, this technology (termed here 'nanopore sequencing') has a comparatively high technical error rate. The present study aimed to assess the utility, accuracy and cost-effectiveness of nanopore sequencing for HCV genomes. We also introduce a new bioinformatics tool (Nano-Q) to differentiate within-host variants from nanopore sequencing. Results The Nanopore platform, when the coverage exceeded 300 reads, generated comparable consensus sequences to Illumina sequencing. Using HCV Envelope plasmids (~ 1800 nt) mixed in known proportions, the capacity of nanopore sequencing to reliably identify variants with an abundance as low as 0.1% was demonstrated, provided the autologous reference sequence was available to identify the matching reads. Successful pooling and nanopore sequencing of 52 samples from patients with HCV infection demonstrated its cost effectiveness (AUD $ 43 per sample with nanopore sequencing versus $ 100 with paired-end short read technology). The Nano-Q tool successfully separated between-host sequences, including those from the same subtype, by bulk sorting and phylogenetic clustering without an autologous reference sequence (using only a subtype-specific generic reference). The pipeline also identified within-host viral variants and their abundance when the parameters were appropriately adjusted. Conclusion Cost effective HCV whole genome sequencing and within-host variant identification without haplotype reconstruction are potential advantages of nanopore sequencing. Keywords: Hepatitis C virus, Third generation sequencing, Nano-Q, Haplotypes, Oxford Nanopore technology Background Hepatitis C (HCV) and many other RNA viruses exist as rapidly mutating quasi-species populations in a single infected host. High throughput characterization of full genome, within-host variants is still not possible despite advances in next generation sequencing. This limitation constrains viral genomic studies that depend on accurate identification of hemi-genome or whole genome, within-host variants, especially those occurring at low frequencies. With the advent of third generation long read sequencing technologies, including Oxford Nanopore Technology (ONT) and PacBio platforms, this problem is potentially surmountable. ONT is particularly attractive in this regard due to the portable nature of the MinION sequencer, which makes real-time sequencing in remote and resource-limited locations possible. However, this technology (termed here ‘nanopore sequencing’) has a comparatively high technical error rate. The present study aimed to assess the utility, accuracy and cost-effectiveness of nanopore sequencing for HCV genomes. We also introduce a new bioinformatics tool (Nano-Q) to differentiate within-host variants from nanopore sequencing. Results The Nanopore platform, when the coverage exceeded 300 reads, generated comparable consensus sequences to Illumina sequencing. Using HCV Envelope plasmids (~ 1800 nt) mixed in known proportions, the capacity of nanopore sequencing to reliably identify variants with an abundance as low as 0.1% was demonstrated, provided the autologous reference sequence was available to identify the matching reads. Successful pooling and nanopore sequencing of 52 samples from patients with HCV infection demonstrated its cost effectiveness (AUD$ 43 per sample with nanopore sequencing versus $100 with paired-end short read technology). The Nano-Q tool successfully separated between-host sequences, including those from the same subtype, by bulk sorting and phylogenetic clustering without an autologous reference sequence (using only a subtype-specific generic reference). The pipeline also identified within-host viral variants and their abundance when the parameters were appropriately adjusted. Conclusion Cost effective HCV whole genome sequencing and within-host variant identification without haplotype reconstruction are potential advantages of nanopore sequencing. Hepatitis C (HCV) and many other RNA viruses exist as rapidly mutating quasi-species populations in a single infected host. High throughput characterization of full genome, within-host variants is still not possible despite advances in next generation sequencing. This limitation constrains viral genomic studies that depend on accurate identification of hemi-genome or whole genome, within-host variants, especially those occurring at low frequencies. With the advent of third generation long read sequencing technologies, including Oxford Nanopore Technology (ONT) and PacBio platforms, this problem is potentially surmountable. ONT is particularly attractive in this regard due to the portable nature of the MinION sequencer, which makes real-time sequencing in remote and resource-limited locations possible. However, this technology (termed here 'nanopore sequencing') has a comparatively high technical error rate. The present study aimed to assess the utility, accuracy and cost-effectiveness of nanopore sequencing for HCV genomes. We also introduce a new bioinformatics tool (Nano-Q) to differentiate within-host variants from nanopore sequencing. The Nanopore platform, when the coverage exceeded 300 reads, generated comparable consensus sequences to Illumina sequencing. Using HCV Envelope plasmids (~ 1800 nt) mixed in known proportions, the capacity of nanopore sequencing to reliably identify variants with an abundance as low as 0.1% was demonstrated, provided the autologous reference sequence was available to identify the matching reads. Successful pooling and nanopore sequencing of 52 samples from patients with HCV infection demonstrated its cost effectiveness (AUD $ 43 per sample with nanopore sequencing versus $ 100 with paired-end short read technology). The Nano-Q tool successfully separated between-host sequences, including those from the same subtype, by bulk sorting and phylogenetic clustering without an autologous reference sequence (using only a subtype-specific generic reference). The pipeline also identified within-host viral variants and their abundance when the parameters were appropriately adjusted. Cost effective HCV whole genome sequencing and within-host variant identification without haplotype reconstruction are potential advantages of nanopore sequencing. |
| ArticleNumber | 148 |
| Audience | Academic |
| Author | Barton, Kirston Riaz, Nasir Smith, Martin A. Rodrigo, Chaturaka Carswell, Shaun Lloyd, Andrew R. Bull, Rowena Leung, Preston |
| Author_xml | – sequence: 1 givenname: Nasir surname: Riaz fullname: Riaz, Nasir organization: Kirby Institute, UNSW Sydney, Department of Microbiology, Hazara University, KPK – sequence: 2 givenname: Preston surname: Leung fullname: Leung, Preston organization: Kirby Institute, UNSW Sydney – sequence: 3 givenname: Kirston surname: Barton fullname: Barton, Kirston organization: Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research – sequence: 4 givenname: Martin A. surname: Smith fullname: Smith, Martin A. organization: Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research – sequence: 5 givenname: Shaun surname: Carswell fullname: Carswell, Shaun organization: Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research – sequence: 6 givenname: Rowena surname: Bull fullname: Bull, Rowena organization: Kirby Institute, UNSW Sydney, Department of Pathology, School of Medical Sciences, UNSW Sydney – sequence: 7 givenname: Andrew R. surname: Lloyd fullname: Lloyd, Andrew R. organization: Kirby Institute, UNSW Sydney – sequence: 8 givenname: Chaturaka orcidid: 0000-0003-2189-9177 surname: Rodrigo fullname: Rodrigo, Chaturaka email: c.rodrigo@unsw.edu.au organization: Kirby Institute, UNSW Sydney, Department of Pathology, School of Medical Sciences, UNSW Sydney |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33653280$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkktv3CAUha0qVfNo_0AXFVI36cIpYDD2ptIo6iNS1Eh9rBHGFw8jD0yBmWSW_edlMukkE1VR8QILvnOAc-9xceC8g6J4TfAZIU39PhLa1KzElJRYsBqX5FlxRJggJSU1O3jwf1gcxzjDmIiG8hfFYVXVvKINPip-T3q1SCpZ75A36OrG-NCjr8r5hQ-AEuip86Mf1ihvoCksMppsROfoeupHQAM4PwcU4dcSnLZuQMr1yPbgkjVW74yvbZpaV059TGhlgxrRSgWrXIovi-dGjRFe3c0nxc9PH3-cfykvrz5fnE8uSy2wSCXhuFI9q4nAtaJgBBedNqwTrNPAOEDbVUBM22DR8bqhBrdQC952pDUdYFqdFBdb396rmVwEO1dhLb2y8nbBh0GqkKweQVKhNFeMa44V69qmJYaqVoPmDSjFdPaqtl5Lt1DrazWOO0OC5aY4clscmYsjb4sjSVZ92KoWy24Ovc4Z5SD2rrK_4-xUDn4lRUsrVm-ecHpnEHzOOyY5t1HDOCoHfhklZW2mmjwy-vYROvPL4HLAknJMBWW8IvfUoPKzrTM-n6s3pnJSc05pjRueqbN_UPnrYW517klj8_qe4N2eIDMJbtKgljHKi-_f9tk3D0PZpfG3RTNAt4AOPsYA5v-ibh6JtN12eb66HZ-W3tU25nPcAOE-uSdUfwA52xp1 |
| CitedBy_id | crossref_primary_10_1099_mgen_0_000920 crossref_primary_10_7717_peerj_17887 crossref_primary_10_1016_j_bbrep_2022_101327 crossref_primary_10_1038_s41598_024_58768_3 crossref_primary_10_3389_fcimb_2024_1432446 crossref_primary_10_3389_fmicb_2023_1294146 crossref_primary_10_1080_21655979_2021_1995991 crossref_primary_10_1002_jmv_29209 crossref_primary_10_1099_mgen_0_000895 crossref_primary_10_1146_annurev_virology_091919_105900 crossref_primary_10_1002_hep4_1929 crossref_primary_10_1007_s00535_024_02146_3 crossref_primary_10_1093_ve_veab079 crossref_primary_10_1016_j_meegid_2022_105242 crossref_primary_10_1093_bib_bbae107 crossref_primary_10_1371_journal_pone_0311555 crossref_primary_10_1186_s12879_023_08423_5 crossref_primary_10_3390_w13182503 |
| Cites_doi | 10.1016/j.bbagen.2018.12.003 10.12688/f1000research.7201.1 10.5694/mja13.00153 10.1111/jvh.12701 10.1038/ncomms11307 10.1371/journal.pntd.0007065 10.1128/JVI.00243-16 10.1038/sdata.2018.17 10.1186/s13059-018-1462-9 10.1016/j.coviro.2011.07.008 10.1093/bioinformatics/btp163 10.1128/JVI.03717-14 10.1186/s12864-016-2575-8 10.1111/dgd.12608 10.1109/MCSE.2007.55 10.1021/j100335a010 10.1111/jvh.12616 10.1109/MCSE.2011.36 10.1038/nrg.2016.49 10.1038/nprot.2017.066 10.1016/j.meegid.2019.02.032 10.1109/MCSE.2007.58 10.1093/nar/gku537 10.1093/bioinformatics/btr627 10.1186/s12864-015-2358-7 10.1093/bioinformatics/btw152 10.1371/journal.ppat.1002243 10.1038/s41467-017-01343-4 10.1109/MCSE.2011.3 10.1093/bioinformatics/bty191 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021 COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2021 – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7QP 7QR 7SS 7TK 7U7 7X7 7XB 88E 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 7X8 5PM ADTOC UNPAY DOA |
| DOI | 10.1186/s12864-021-07460-1 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Entomology Abstracts (Full archive) Neurosciences Abstracts Toxicology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection Toxicology Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen Free (Free internet resource, activated by CARLI) url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 6 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1471-2164 |
| EndPage | 12 |
| ExternalDocumentID | oai_doaj_org_article_27ac5a45c50a4b9891f2a9cec58eaa4c 10.1186/s12864-021-07460-1 PMC7923462 A655226085 33653280 10_1186_s12864_021_07460_1 |
| Genre | Journal Article |
| GeographicLocations | Australia |
| GeographicLocations_xml | – name: Australia |
| GrantInformation_xml | – fundername: National Health and Medical Research Council grantid: 1137587; 1084706; 1150078; 1173666 funderid: http://dx.doi.org/10.13039/501100000925 – fundername: University of New South Wales grantid: 2018-ECR-001 funderid: http://dx.doi.org/10.13039/501100001773 – fundername: National Health and Medical Research Council grantid: 1084706 – fundername: University of New South Wales grantid: 2018-ECR-001 – fundername: National Health and Medical Research Council grantid: 1137587 – fundername: National Health and Medical Research Council grantid: 1150078 – fundername: National Health and Medical Research Council grantid: 1173666 – fundername: ; grantid: 1137587; 1084706; 1150078; 1173666 – fundername: ; grantid: 2018-ECR-001 |
| GroupedDBID | --- 0R~ 23N 2WC 2XV 53G 5VS 6J9 7X7 88E 8AO 8FE 8FH 8FI 8FJ AAFWJ AAHBH AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK IAO IGS IHR INH INR ISR ITC KQ8 LK8 M1P M48 M7P M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAYXX CITATION ALIPV CGR CUY CVF ECM EIF NPM 3V. 7QP 7QR 7SS 7TK 7U7 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ K9. P64 PKEHL PQEST PQUKI PRINS RC3 7X8 5PM 2VQ 4.4 ADRAZ ADTOC AHSBF C1A EJD H13 HYE IPNFZ RIG UNPAY |
| ID | FETCH-LOGICAL-c707t-1503ad461706a2ef757bcf4b74bce45ee9b3e1f9807b5682f09e6759b19fbe023 |
| IEDL.DBID | M48 |
| ISSN | 1471-2164 |
| IngestDate | Fri Oct 03 12:45:43 EDT 2025 Sun Oct 26 03:59:57 EDT 2025 Tue Sep 30 16:41:36 EDT 2025 Fri Sep 05 08:25:53 EDT 2025 Tue Oct 07 05:24:49 EDT 2025 Mon Oct 20 21:53:40 EDT 2025 Mon Oct 20 16:22:32 EDT 2025 Thu Oct 16 14:24:20 EDT 2025 Thu Apr 03 06:53:04 EDT 2025 Wed Oct 01 01:08:18 EDT 2025 Thu Apr 24 23:04:40 EDT 2025 Sat Sep 06 07:30:27 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Haplotypes Third generation sequencing Hepatitis C virus Nano-Q Oxford Nanopore technology |
| Language | English |
| License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. cc-by |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c707t-1503ad461706a2ef757bcf4b74bce45ee9b3e1f9807b5682f09e6759b19fbe023 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-2189-9177 |
| OpenAccessLink | https://link.springer.com/10.1186/s12864-021-07460-1 |
| PMID | 33653280 |
| PQID | 2502724531 |
| PQPubID | 44682 |
| PageCount | 12 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_27ac5a45c50a4b9891f2a9cec58eaa4c unpaywall_primary_10_1186_s12864_021_07460_1 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7923462 proquest_miscellaneous_2496238888 proquest_journals_2502724531 gale_infotracmisc_A655226085 gale_infotracacademiconefile_A655226085 gale_incontextgauss_ISR_A655226085 pubmed_primary_33653280 crossref_primary_10_1186_s12864_021_07460_1 crossref_citationtrail_10_1186_s12864_021_07460_1 springer_journals_10_1186_s12864_021_07460_1 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2021-03-02 |
| PublicationDateYYYYMMDD | 2021-03-02 |
| PublicationDate_xml | – month: 03 year: 2021 text: 2021-03-02 day: 02 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC genomics |
| PublicationTitleAbbrev | BMC Genomics |
| PublicationTitleAlternate | BMC Genomics |
| PublicationYear | 2021 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | C Rodrigo (7460_CR12) 2017; 24 RA Bull (7460_CR14) 2016; 17 P Leung (7460_CR4) 2018 H Li (7460_CR25) 2016; 32 BD Betz-Stablein (7460_CR21) 2016; 90 TE Oliphant (7460_CR27) 2007; 9 CL Ip (7460_CR9) 2015; 4 C Rodrigo (7460_CR2) 2019; 1863 MCF Prosperi (7460_CR7) 2012; 28 A Abayasingam (7460_CR20) 2019; 71 RA Bull (7460_CR15) 2011; 7 FJ Rang (7460_CR17) 2018; 19 GK Thiruvathukal (7460_CR29) 2011; 13 J Quick (7460_CR11) 2017; 12 KJ Millman (7460_CR28) 2011; 13 M Eigen (7460_CR3) 1988; 92 B White (7460_CR23) 2014; 201 FD Giallonardo (7460_CR8) 2014; 42 FG Naveca (7460_CR10) 2019; 13 N Beerenwinkel (7460_CR6) 2011; 1 NC Wu (7460_CR13) 2016; 17 EB Cunningham (7460_CR22) 2017; 24 JD Hunter (7460_CR30) 2007; 9 S Goodwin (7460_CR5) 2016; 17 H Li (7460_CR31) 2018; 34 M Cretu Stancu (7460_CR18) 2017; 8 I Sović (7460_CR24) 2016; 7 MEJ Woolhouse (7460_CR1) 2018; 5 7460_CR19 RA Bull (7460_CR16) 2015; 89 PJ Cock (7460_CR26) 2009; 25 |
| References_xml | – volume: 1863 start-page: 511 issue: 2 year: 2019 ident: 7460_CR2 publication-title: Biochim Biophys Acta Gen Subj doi: 10.1016/j.bbagen.2018.12.003 – volume: 4 start-page: 1075 year: 2015 ident: 7460_CR9 publication-title: F1000Research doi: 10.12688/f1000research.7201.1 – volume: 201 start-page: 326 issue: 6 year: 2014 ident: 7460_CR23 publication-title: Med J Aust doi: 10.5694/mja13.00153 – volume: 24 start-page: 733 issue: 9 year: 2017 ident: 7460_CR22 publication-title: J Viral Hepat doi: 10.1111/jvh.12701 – volume: 7 start-page: 11307 year: 2016 ident: 7460_CR24 publication-title: Nat Commun doi: 10.1038/ncomms11307 – volume-title: Bioinformatics and statistical methods to study the evolution of primary HCV infection year: 2018 ident: 7460_CR4 – volume: 13 start-page: e0007065 issue: 3 year: 2019 ident: 7460_CR10 publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0007065 – volume: 90 start-page: 7171 issue: 16 year: 2016 ident: 7460_CR21 publication-title: J Virol doi: 10.1128/JVI.00243-16 – volume: 5 start-page: 180017 year: 2018 ident: 7460_CR1 publication-title: Sci Data doi: 10.1038/sdata.2018.17 – volume: 19 start-page: 90 issue: 1 year: 2018 ident: 7460_CR17 publication-title: Genome Biol doi: 10.1186/s13059-018-1462-9 – volume: 1 start-page: 413 issue: 5 year: 2011 ident: 7460_CR6 publication-title: Curr Opin Virol doi: 10.1016/j.coviro.2011.07.008 – volume: 25 start-page: 1422 issue: 11 year: 2009 ident: 7460_CR26 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp163 – volume: 89 start-page: 5478 issue: 10 year: 2015 ident: 7460_CR16 publication-title: J Virol doi: 10.1128/JVI.03717-14 – volume: 17 start-page: 247 issue: 1 year: 2016 ident: 7460_CR14 publication-title: BMC Genomics doi: 10.1186/s12864-016-2575-8 – ident: 7460_CR19 doi: 10.1111/dgd.12608 – volume: 9 start-page: 90 issue: 3 year: 2007 ident: 7460_CR30 publication-title: Comput Sci Eng doi: 10.1109/MCSE.2007.55 – volume: 92 start-page: 6881 year: 1988 ident: 7460_CR3 publication-title: J Phys Chem doi: 10.1021/j100335a010 – volume: 24 start-page: 43 issue: 1 year: 2017 ident: 7460_CR12 publication-title: J Viral Hepat doi: 10.1111/jvh.12616 – volume: 13 start-page: 9 issue: 2 year: 2011 ident: 7460_CR28 publication-title: Comput Sci Eng doi: 10.1109/MCSE.2011.36 – volume: 17 start-page: 333 issue: 6 year: 2016 ident: 7460_CR5 publication-title: Nat Rev Genet doi: 10.1038/nrg.2016.49 – volume: 12 start-page: 1261 issue: 6 year: 2017 ident: 7460_CR11 publication-title: Nat Protoc doi: 10.1038/nprot.2017.066 – volume: 71 start-page: 36 year: 2019 ident: 7460_CR20 publication-title: Infect Genet Evol doi: 10.1016/j.meegid.2019.02.032 – volume: 9 start-page: 10 issue: 3 year: 2007 ident: 7460_CR27 publication-title: Comput Sci Eng doi: 10.1109/MCSE.2007.58 – volume: 42 start-page: e115 issue: 14 year: 2014 ident: 7460_CR8 publication-title: Nucleic Acids Res doi: 10.1093/nar/gku537 – volume: 28 start-page: 132 issue: 1 year: 2012 ident: 7460_CR7 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btr627 – volume: 17 start-page: 46 year: 2016 ident: 7460_CR13 publication-title: BMC Genomics doi: 10.1186/s12864-015-2358-7 – volume: 32 start-page: 2103 issue: 14 year: 2016 ident: 7460_CR25 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btw152 – volume: 7 issue: 9 year: 2011 ident: 7460_CR15 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1002243 – volume: 8 start-page: 1326 issue: 1 year: 2017 ident: 7460_CR18 publication-title: Nat Commun doi: 10.1038/s41467-017-01343-4 – volume: 13 start-page: 5 issue: 1 year: 2011 ident: 7460_CR29 publication-title: Comput Sci Eng doi: 10.1109/MCSE.2011.3 – volume: 34 start-page: 3094 issue: 18 year: 2018 ident: 7460_CR31 publication-title: Bioinformatics doi: 10.1093/bioinformatics/bty191 |
| SSID | ssj0017825 |
| Score | 2.455742 |
| Snippet | Background
Hepatitis C (HCV) and many other RNA viruses exist as rapidly mutating quasi-species populations in a single infected host. High throughput... Hepatitis C (HCV) and many other RNA viruses exist as rapidly mutating quasi-species populations in a single infected host. High throughput characterization of... Background Hepatitis C (HCV) and many other RNA viruses exist as rapidly mutating quasi-species populations in a single infected host. High throughput... Abstract Background Hepatitis C (HCV) and many other RNA viruses exist as rapidly mutating quasi-species populations in a single infected host. High throughput... |
| SourceID | doaj unpaywall pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 148 |
| SubjectTerms | Abundance Accuracy Algorithms Animal Genetics and Genomics Bioinformatics Biomedical and Life Sciences Clustering Comparative and evolutionary genomics Computational biology Cost effectiveness Diagnosis DNA sequencing Drug resistance Gene sequencing Genetic aspects Genomes Genomics Haplotypes Health aspects Hepatitis Hepatitis C Hepatitis C virus High-Throughput Nucleotide Sequencing Humans Infections Life Sciences Methods Microarrays Microbial Genetics and Genomics Mutation Nano-Q Nanopores Next-generation sequencing Nucleotide sequencing Oxford Nanopore technology Parameter identification Phylogenetics Phylogeny Plant Genetics and Genomics Plasmids Porosity Proteomics Research Article RNA viruses Sequence Analysis, DNA Technology Third generation sequencing Viral infections Viruses Whole Genome Sequencing |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJQQcEG9SCjIIiQONmjh2bB-Xiqpw4ABU6s2yHYeutE1WJEvVY_85M3mxAalwIMd4EsWe8Xgm_vwNIa-dt8zD0hdLH2TMM-djJz2LfVG6pJRFZosOIPspPz7hH0_F6VapL8SE9fTA_cAdMGm9sFx4kVjutNJpyaz2wQsVrOUevW-i9JhMDfsHsO6J8YiMyg8a8MI5jxGOgPU1kjidLUMdW_-fPnlrUfodMDntmt4htzbV2l5e2NVqa2E6ukfuDhElXfQ9uU9uhOoBudnXmLx8SK4WhV33--20Lml_QJCCU60h8g60nX6tU2igZwER1u2yoYf0AkvnUiRxPQ90gFzD11BbFXRZDCij6cX4Q3dZxXhohCJweEV_QBqOKJtH5OTo_dfD43iouxB7mcg2hhgRVMSRqj23LJRSSOdL7iR3PnARgnZZSEutEulErliZ6AB5h3apLl2AIOAx2anqKjwllBcu5VYJC1kkl85aeKHFpCtxnnshIpKOajB-ICXH2hgr0yUnKje96gyoznSqM2lE3k7PrHtKjmul36F2J0mk0-5ugJGZwcjM34wsIq_QNgwSZlSIyPlmN01jPnz5bBa5wBAWIteIvBmEyhr64O1wwAFGAjm2ZpJ7M0mY0X7ePJqgGTxKYyBUZZJxcJkReTk145OIkqtCvQEZriGaVXBF5ElvsVO_sywXGVNJROTMlmcDM2-plmcd3zhSTPKcRWR_tPpfn3XdwO9PM-Mf9LT7P_T0jNxm3SRHbMIe2Wm_b8JzCBpb96LzDz8B_pVo7w priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6VrRBwQLwJFGQQEgcaNfHacXJAaFu1KhxWqFCpN8t2nHalJVm6u1Q98s-ZyasNSBV7XE-i2PPw2P78DcA76wx3OPWFynkVirF1oVWOhy4vbFSofGzyGiA7TQ6PxZcTebIB0-4uDMEqu5hYB-q8crRHvoNTNVdcoMl8WvwMqWoUna52JTRMW1oh_1hTjN2CTU7MWCPY3N2ffj3qzxVwPpTd1Zk02VlidE5ESDAFqrsRhfFgeqpZ_P-N1dcmq7-BlP1p6j24sy4X5vLCzOfXJqyDB3C_zTTZpDGNh7Dhy0dwu6k9efkYfk9ys2jO4VlVsObiIMNgW2FG7tmq33Jn2MDOPCGvV7Ml22MXVFKXEbnrD89aKDZ-DTNlzmZ5iz7qX0wbvbMypMskjADFc_YLl-eEvnkCxwf73_cOw7YeQ-hUpFYh5o6oOkEU7onhvlBSWVcIq4R1XkjvMzv2cZGlkbIySXkRZR7XI5mNs8J6TA6ewqisSv8cmMhtLEwqDa4uhbLG4AsNLcYi64STMoC4U4N2LVk51cyY63rRkia6UZ1G1eladToO4EP_zKKh6rhRepe020sSzXb9R3V-qluv1VwZJ_G7nIyMsFmaxQU3mfNOpt4Y4QJ4S7ahiUijJKTOqVkvl_rztyM9SSSltpjRBvC-FSoq7IMz7cUHHAni3hpIbg0k0dPdsLkzQd1GmqW-8osA3vTN9CSh50pfrVFGZJjlpvgL4FljsX2_x-NEjnkaBaAGtjwYmGFLOTureciJelIkPIDtzuqvPuumgd_uPeM_9PTi5k6_hLu8dl9CI2zBaHW-9q8wTVzZ163v_wEuumWq priority: 102 providerName: ProQuest – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZQEQIOiDeBggxC4kCtJo4dJ8eloiocOAAr9WbZjt2utCSrJkvVI_-cmbxoAFWQYzy2HM94PBN__kzIa-sMd7D0MeW8YiK1jlnlOHNlsHFQZWrKDiD7KTtaio_H8ng4FNaMaPdxS7Lz1N20zrP9BjxpJhhCCvCOjJhBznNdIp0XWPGSL6a9A1jz5Hg85q_1ZktQx9T_pz--tCD9Dpacdkxvk5vbamMuzs16fWlROrxL7gzRJF306r9HrvnqPrnR3y958YD8WJRm0--10zrQ_nAgBYdaQ9TtaTv9VqdQQE89oqvbVUMP6Dlem0uRwPWbpwPcGnpDTVXSVTkgjKaG8WfuqmJ4YIQiaHhNv0MKjgibh2R5-P7rwREb7lxgTsWqZRAfgnoE0rRnhvugpLIuCKuEdV5I7wub-iQUeayszHIe4sJDzlHYpAjWQwDwiOxUdeWfECpKmwiTSwMZpFDWGGjQYMIVWyeclBFJRjVoNxCS470Ya90lJnmme9VpUJ3uVKeTiLyd6mx6Oo4rpd-hdidJpNLuXtRnJ3qYmZor4yT0y8nYCFvkRRK4KZx3MvfGCBeRV2gbGskyKkTjnJht0-gPXz7rRSYxfIWoNSJvBqFQwzc4MxxugJFAfq2Z5O5MEmazmxePJqgHb9JoCFO54gLcZUReTsVYExFyla-3ICMKiGRzeCLyuLfY6bvTNJMpz-OIqJktzwZmXlKtTjuucaSXFBmPyN5o9b-6ddXA700z4x_09PT_Wn9GbvFuOiMCYZfstGdb_xxCw9a-6DzBT1GRXC4 priority: 102 providerName: Springer Nature – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfQJgQ88D0IDGQQEg8sXeLYcfJYJqbBw4SASuPJsh1nq9ol1ZIyjTf-c-6SNDQDTSDRp6g-R_bl7nyX_O6OkFfGambh6POlddLnkbG-kZb5NstNkMss0lkDkD2MDyb8w5E46vBPmAtjTi0WJz2d2mq0noA-b6w2XNjZ7iLLW2VP4t0K7GvMfQQaYOeMwIdIaDMW4JdvkM3J4cfx1ya9SIY-g8BglTXzx4mDk6kp4P-7mV47py5jKPsPqbfIjWWx0Bfnej5fO6v275DZapctRGU2WtZmZL9fKgD5f9hwl9zuXFo6bmXwHrnmivvketvk8uIB-THO9KL94E_LnLYZihSsegmuv6N1_26fwgA9cQjxrqcV3aPn2LuXNit0tMN8w96pLjI6zTqYU39jfKM8LXzMWqGIXJ7Tbxq0q6irh2Sy_-7L3oHfNX7wrQxk7YOTCjLCsVZ8rJnLpZDG5txIbqzjwrnURC7M0ySQRsQJy4PUQeCTmjDNjQMvZItsFGXhHhPKMxNynQgNYSyXRmu4ocaoLzCWWyE8Eq4eurJdVXRszjFXTXSUxKplrQLWqoa1KvTIm37Ooq0JciX1W5SlnhLreTd_lGfHqjMPikltBazLikBzkyZpmDOdWmdF4rTm1iMvURIVVuwoEBJ0rJdVpd5__qTGsUAfGlxnj7zuiPISRUR3GRbACSzyNaDcHlCCSbHD4ZXAq86kVQp8ZSYZB5vtkRf9MM5EmF7hyiXQ8BTc6QR-HnnU6ke_7yiKRcSSwCNyoDkDxgxHiulJU_Aca1zymHlkZ6Vjv5Z1FeN3ej38i-f05N_In5KbrFE3hEFsk436bOmegX9am-ed4fkJPoSJmA priority: 102 providerName: Unpaywall |
| Title | Adaptation of Oxford Nanopore technology for hepatitis C whole genome sequencing and identification of within-host viral variants |
| URI | https://link.springer.com/article/10.1186/s12864-021-07460-1 https://www.ncbi.nlm.nih.gov/pubmed/33653280 https://www.proquest.com/docview/2502724531 https://www.proquest.com/docview/2496238888 https://pubmed.ncbi.nlm.nih.gov/PMC7923462 https://bmcgenomics.biomedcentral.com/track/pdf/10.1186/s12864-021-07460-1 https://doaj.org/article/27ac5a45c50a4b9891f2a9cec58eaa4c |
| UnpaywallVersion | publishedVersion |
| Volume | 22 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: RBZ dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: KQ8 dateStart: 20000701 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: KQ8 dateStart: 20000101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: DOA dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: ABDBF dateStart: 20000101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: DIK dateStart: 20000101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: M~E dateStart: 20000101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: RPM dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1471-2164 dateEnd: 20250331 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: M48 dateStart: 20000701 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: HAS SpringerNature Open Access 2022 customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: AAJSJ dateStart: 20001201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: U2A dateStart: 20001201 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerOpen Free (Free internet resource, activated by CARLI) customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: C6C dateStart: 20000112 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfGKmA8IL4JjMogJB5YIB92nDwg1FWbBhLVNKhUnizbcbZKJS39YPSR_5y7fK2BMdGHqqnPkeO78905P98R8lIbFRgwfa4wVrgs1MbVwgSuSTPtZSINVVoAZAfR0ZB9HPHRFqnLHVUTuLg0tMN6UsP55M3P7-v3oPDvCoWPo7cLWGMj5iLYAKtneC5EQx2wVAmWcvjELt4qgDXk9cGZS_vtkBthGPEwwCyRG3aqSOf_96K9YbX-RFQ2r1VvkZurfKbW52oy2bBch3fI7crlpL1SRu6SLZvfI9fLIpTr--RXL1Wz8oU8nWa0PEFIYdWdwqxYumz23ik00DOLEOzleEH79Bxr61LM8vrN0gqTDaOhKk_pOK1gSM2Nccd3nLt4qoQisnhCf0CcjjCcB2R4ePClf-RWhRlcIzyxdMGJBB4yzOUeqcBmggttMqYF08Yybm2iQ-tnSewJzaM4yLzEQmCSaD_JtAUv4SHZzqe5fUwoS7XPVMwVhJlMaKXghgqjMk8bZjh3iF-zQZoqazkWz5jIInqJI1lyUQIXZcFF6TvkddNnVubsuJJ6H7nbUGK-7eKP6fxUVuorA6EMh3EZ7immkzjxs0AlxhoeW6WYccgLlA2JGTVyhOycqtViIT98PpG9iKOPC66tQ15VRNkUnsGo6gQEzAQm4WpR7rYoQeVNu7kWQVlrjARfNhABgzXVIc-bZuyJMLrcTldAwxJwd2P4OORRKbHNc9eC7xDRkuXWxLRb8vFZkZAcc1CyKHDIXi31F8O6auL3Gs34Dz49-eeIn5KdoFBiRCTsku3lfGWfgau41F1yTYxEl3T2DwbHJ3DVj_rdYtulW6wM8D0M4HdnODjuff0NH79pGg |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dT9UwFG8IxKAPxm-nqNVofJCFrWvX7YEYQAgIEoOS8FbbroObXLcru1fCo_-Yf5vn7AumCfGF-3h7trQ7p-ejPed3CHltrGYWTJ8vrZM-j4z1jbTMt1luglxmkc7qBNn9ePuQfzwSR3Pkd1cLg2mVnU6sFXVWWjwjXwFTzSTjIDLvJz987BqFt6tdCw3dtlbIVmuIsbawY9edn0EIV63ufAB-v2Fsa_PrxrbfdhnwrQzk1AePCCbEEZg81szlUkhjc24kN9Zx4VxqIhfmaRJII-KE5UHqwMtOTZjmxtXAB2ACFnjEUwj-FtY39z8f9PcYYH9FV6qTxCsVWIOY-5gWgX0-Aj8cmMO6a8C_tuGScfw7cbO_vb1FFmfFRJ-f6fH4koHcukNut54tXWtE8S6Zc8U9cqPpdXl-n_xay_SkufenZU6bQkUKyr2ECMDRaX_ET2GAnjjM9J6OKrpBz7CFL0Uw2e-OtqnfMBuqi4yOsjbbqX8xHiyPCh-LVygmMI_pTw2brJhWD8jhtXDmIZkvysI9JpRnJuQ6ERqiWS6N1vBCjcFfYCy3Qngk7NigbAuOjj06xqoOkpJYNaxTwDpVs06FHnnXPzNpoEGupF5H7vaUCOtd_1GeHqtWSygmtRUwLysCzU2apGHOdGqdFYnTmluPvELZUAjcUWBm0LGeVZXa-XKg1mKBrjR40B552xLlJazB6rbQAr4EYn0NKJcGlKBZ7HC4E0HVarZKXexDj7zsh_FJzNYrXDkDGp6CV53AzyOPGont1x1FsYhYEnhEDmR58GGGI8XopMY9R6hLHjOPLHdSfzGtqz78cr8z_oNPT65e9AuyuP31057a29nffUpusnorYybEEpmfns7cM3BRp-Z5qwco-XbdqucP3n6iiA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZQEa8D4k2ggEFIHGjUxLHj5LgsrFpAFQIq9WbZjt2utCSrJkvVI_-cmSQbNoAq2ON6bCWe8Tzib2YIeWmsZhZMXyitkyFPjA2NtCy0hTeRl0WiixYge5DuHfL3R-JoI4u_RbuvryS7nAas0lQ2u8vCd0c8S3dr0KopDxFegP0yohDin8scrBv2MJim0-EeAeyfWKfK_HXeyBy1Vfv_1M0bxul34ORwe3qDXFuVS31-pheLDQM1u0Vu9p4lnXSicJtccuUdcqXrNXl-l_yYFHrZ3bvTytMuUZCCcq3AA3e0GT6xUxigJw6R1s28plN6hi10KRZz_eZoD72Gp6G6LOi86NFGw8L4YXdehpg8QhFAvKDfIRxHtM09cjh793W6F_b9F0IrI9mE4CsCqziWbE81c14KaaznRnJjHRfO5SZxsc-zSBqRZsxHuYP4Izdx7o0DZ-A-2Sqr0j0klBcm5joTGqJJLo3WsKDG4CsyllshAhKv2aBsX5wce2QsVBukZKnqWKeAdaplnYoD8nqYs-xKc1xI_Qa5O1BiWe32j-r0WPWnVDGprYDnsiLS3ORZHnumc-usyJzW3AbkBcqGwsIZJSJzjvWqrtX-l89qkgp0ZcGDDcirnshX8A5W94kOsBNYa2tEuT2ihJNtx8NrEVS9ZqkVuKxMMg6qMyDPh2GciWi50lUroOE5eLUZ_ALyoJPY4b2TJBUJy6KAyJEsjzZmPFLOT9q641hqkqcsIDtrqf_1WBdt_M5wMv6BT4_-b_Vn5OqntzP1cf_gw2NynbUnG4EJ22SrOV25J-AxNuZpqxR-AvUcY0A |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfQJgQ88D0IDGQQEg8sXeLYcfJYJqbBw4SASuPJsh1nq9ol1ZIyjTf-c-6SNDQDTSDRp6g-R_bl7nyX_O6OkFfGambh6POlddLnkbG-kZb5NstNkMss0lkDkD2MDyb8w5E46vBPmAtjTi0WJz2d2mq0noA-b6w2XNjZ7iLLW2VP4t0K7GvMfQQaYOeMwIdIaDMW4JdvkM3J4cfx1ya9SIY-g8BglTXzx4mDk6kp4P-7mV47py5jKPsPqbfIjWWx0Bfnej5fO6v275DZapctRGU2WtZmZL9fKgD5f9hwl9zuXFo6bmXwHrnmivvketvk8uIB-THO9KL94E_LnLYZihSsegmuv6N1_26fwgA9cQjxrqcV3aPn2LuXNit0tMN8w96pLjI6zTqYU39jfKM8LXzMWqGIXJ7Tbxq0q6irh2Sy_-7L3oHfNX7wrQxk7YOTCjLCsVZ8rJnLpZDG5txIbqzjwrnURC7M0ySQRsQJy4PUQeCTmjDNjQMvZItsFGXhHhPKMxNynQgNYSyXRmu4ocaoLzCWWyE8Eq4eurJdVXRszjFXTXSUxKplrQLWqoa1KvTIm37Ooq0JciX1W5SlnhLreTd_lGfHqjMPikltBazLikBzkyZpmDOdWmdF4rTm1iMvURIVVuwoEBJ0rJdVpd5__qTGsUAfGlxnj7zuiPISRUR3GRbACSzyNaDcHlCCSbHD4ZXAq86kVQp8ZSYZB5vtkRf9MM5EmF7hyiXQ8BTc6QR-HnnU6ke_7yiKRcSSwCNyoDkDxgxHiulJU_Aca1zymHlkZ6Vjv5Z1FeN3ej38i-f05N_In5KbrFE3hEFsk436bOmegX9am-ed4fkJPoSJmA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adaptation+of+Oxford+Nanopore+technology+for+hepatitis+C+whole+genome+sequencing+and+identification+of+within-host+viral+variants&rft.jtitle=BMC+genomics&rft.au=Riaz%2C+Nasir&rft.au=Leung%2C+Preston&rft.au=Barton%2C+Kirston&rft.au=Smith%2C+Martin+A&rft.date=2021-03-02&rft.eissn=1471-2164&rft.volume=22&rft.issue=1&rft.spage=148&rft_id=info:doi/10.1186%2Fs12864-021-07460-1&rft_id=info%3Apmid%2F33653280&rft.externalDocID=33653280 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2164&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2164&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2164&client=summon |